Neurotoxicity in children after treatment for acute lymphoblastic leukaemia and methotrexate neurotoxicity in a controlled animal model
Abstract In the Nordic countries, event-free survival (EFS) exceeds 80% in certain groups of children treated for acute lymphoblastic leukaemia (ALL). With the improved cure rates, however, there are more children suffering from neurological late effects, especially due to therapy directed at the c...
Main Author: | Lehtinen, S. (Satu) |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
University of Oulu
2003
|
Subjects: | |
Online Access: | http://urn.fi/urn:isbn:9514270339 http://nbn-resolving.de/urn:isbn:9514270339 |
Similar Items
-
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
by: Kotnik Barbara Faganel, et al.
Published: (2017-09-01) -
A retrospective study of acute lymphoblastic leukaemia in Paediatric patients at Dr George Mukhari Hospital (2003-2007)
by: Swanepoel, Yolande
Published: (2010) -
The impact of homocysteine level on methotrexate induced neurotoxicity in children treated with St. Jude total XV acute lymphoblastic leukemia protocol
by: Wael Zekri, et al.
Published: (2016-03-01) -
Aggressive lung involvement in a patient with T‐acute lymphoblastic leukaemia/lymphoblastic lymphoma: a tricky and rare case report
by: Chika Miyaoka, et al.
Published: (2020-08-01) -
Targeted Therapy in Acute Lymphoblastic Leukaemia
by: Ross Salvaris, et al.
Published: (2021-07-01)